Development Bank of Wales

"Representation in video games is more important than ever, and technological limitations have long constrained the scale of customization developers could offer. With our proprietary technology and our upcoming game “YOU VS ZOMBIES”, we’re breaking those barriers—creating fully personalized, ever-evolving experiences for every player. This level of customization was previously unattainable, but thanks to advancements in generative AI, we’re making it a reality right here inWales."

"We are delighted to have the continued support of our existing investors, as well as the new investors who share our vision for revolutionizing the car insurance industry. This funding will enable us to accelerate our growth and expand our reach, ultimately benefiting both insurers and policyholders."

"Pelly bridges the gap between data and action. We’ve built a platform that leverages AI to turn complex data into clear, actionable insights for clubs. Our focus is empowering teams to operate with agility, integrating the data they already have, and providing tools that help them win—both on and off the pitch. We’ve been working closely with international academic institutions to develop our prototype. Over 100 industry professionals have been consulted to date, and eight football clubs are now testing the product before going to market in the next few months. The support of our team, advisors, and investors is helping us to accelerate our growth. They’re encouraging us to work smarter whilst opening doors and providing the working capital that we need to fund our early-stage development. It’s a huge vote of confidence in us, our business model, and our potential as a young and driven team."

"UTI prevalence is rising with an ageing population and the increase in antibiotic resistant infections. The gold standard for UTI diagnosis is microbiological urine culture and, in the UK, millions of urine tests are processed and cultured each year. However, a major drawback of urine culture systems is the time lag of approximately two days between specimen collection and pathogen identification. Fast and accurate diagnosis, leading to a rational treatment, is essential to achieve a timely and effective therapy."

"The elderly population is rapidly growing, and the care sector is struggling to keep pace. We need over a 50% increase in paid carers by 2030 to ensure adequate care. The current situation calls for innovative AI solutions, like Hestia, to address the urgent need for caregivers and fulfil the care sector’s economic and job creation potential,"

"As a legal technology business, we offer compliance management software that allows regulated businesses to save time and reduce costs with end-to-end compliance requirements."

"We’re stoked to close this round and onboard Puma Private Equity as we accelerate growth in the UK and Europe, the next big step in our mission to protect the world’s riders. Working with a company aligned with our values combined with their depth of experience in international growth across a wide range of technology-enabled sectors is a perfect match for Bikmo."

"We set up tourhub because we could see the growth of experiential travel and cultural holidays, but there was a need to bring it all in one place for travellers. We offer everything else but the standard, traditional beach package holidays. With close to over 800 worldwide suppliers, we provide you with whatever you dream of – from seeing snow monkeys in the Japanese Alps, hiking around 18 national parks in America, to cycling tours across Vietnam – we have something for every type of adventure seeker, no matter what your age."

"We’re pleased to have backed CanSense during this investment round with equity support. Their testing technology shows huge potential, with benefits for NHS backlogs if adopted widely, and we’re glad to support the work of this company as it brings its expertise to Wales’ increasingly strong med-tech sector."

"This is the most comprehensive validation of our platform thus far. While identifying antibodies to GPCRs has traditionally been a complex and time-intensive process requiring expensive specialist technology and training, we have demonstrated that Antiverse’s drug discovery platform can achieve this in a fraction of the time and cost. GPCRs are commercially interesting targets associated with various indications, and these antibodies offer a path to first in vivo results and can potentially be our first assets. I would like to thank our investors, this funding will enable us to continue to develop these assets in-house with our academic collaborators."

"From Pakistan to Dubai then Poland to Cardiff, this has been a three year journey that started in my home garage fondly known as the ‘Gar-Office’."

"The technology is unique in the emissions monitoring marketplace in its potential to achieve the greatest amount of GHG abatement at the lowest cost of ownership,"

"Our platform captures accurate, intelligent, real-time insights into the movement of people and vehicles – without infringing on individual privacy – to enable better, more efficient traffic management, place-making and urban planning across towns and cities globally. From reducing wait times at traffic lights and easing congestion for emergency services access, to improving customer experiences at stadiums and retail outlets, the application of accurate and anonymous movement insights has universal potential."

"This has been another important year of growth and development for Bond Digital Health. Now that we have several international customers signed up to our platform, we need to make sure we successfully service their needs 24/7. This funding will help us do that by ensuring we have the right people in the right roles. I’d like to put on record my thanks to the Development Bank of Wales and Wealth Club for helping us get to this point."

"We’ve worked hard over the last few years to develop Tahdah as a secure online feature-packed management system that can be tailored to meet the bespoke needs of our customer base."

"This funding round will enable us to scale up our development and launch our business providing next-generation greenhouse gas monitoring. Our unique quantum Lidar is the right solution for the challenge of how to effectively measure industrial methane emissions, and meet the major commitments that the oil and gas majors have made to control their greenhouse gas emissions."

"Our investors recognise the potential of our AI-powered antibody drug discovery platform to provide a breakthrough in the industry. With our technology, it will be possible to develop drugs for difficult targets and ultimately reduce drug discovery timescales from years to weeks. In addition to platform development, the funding will enable us to invest in facilities and recruitment; we are grateful to our investors and Innovate UK for their continued support."

"We’re delighted to have secured our first equity investment and very much look forward to continuing to grow and develop alongside the Development Bank of Wales and our Angel co-investors."

"Our purpose has always been to help people be better with data. This funding is a fantastic recognition of our hard work and shows a strong belief and confidence in our forward mission as a business."

"Coincover helps crypto businesses to address the security concerns of the cautious investor and delivers the trust mark they need to stand out in a crowded and wary market. We are the only company in the world with a security product that is backed by Lloyds of London, providing protection from cryptocurrency theft at the individual level and an opportunity to maximise business revenue by enabling our partners to build systems that creates strong trust with their clients."

"With heightened emphasis on the criticality of excellent technology infrastructure, all businesses should be able to maximise the benefits of Infrastructure as Code to speed up software delivery, reduce costs, and improve product quality. Whether it is because of a skills gap, a lack of knowledge, or aninability to deploy it at scale, Infrastructure as Code needs to be made more accessible to a wider cross-section of the business community. We’re excited to launch our platform into that space."

"We are delighted to be working with the Development Bank of Wales who were always our preferred key strategic partner for the company and our plans in Wales. Wales is a world leader in both farming and technology. We aim to bridge both of those skills to create innovation in the food supply chain both domestically and internationally."

"DataVoyant connects to any internal or external source and analyses both structured and unstructured data. It enables users to uncover market signals and trends, improve debt management, control risk better, and rapidly identify emerging opportunities. Our technology delivers unprecedented insights, well beyond what traditional providers are capable of"

"BookingLive is set to grow rapidly in the next two years, as we continue our success in the UK and look to replicate that success in the US. Securing the backing of both Blackfinch and the Development Bank of Wales is a great vote of confidence in our company and in our product."

"Deepbridge is committed to fostering innovation and growth in businesses with truly disruptive market potential, and we believe that Thalia definitely falls into that category,"

"Throughout my international practice in speech therapy, I have wanted to develop an innovative treatment that will help people communicate again after a stroke, brain injury, Parkinson’s or Dementia."

"The nature of our business means that we could have set it up anywhere in the world,"